# Antidote Therapeutics, Inc. — Form D

Antidote Therapeutics, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2017-09-11. The offering totals $200K, of which $200K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-09-11
- Form: D
- Accession: 0001716110-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $200K
- Investors: 1
- Date of first sale: 2017-06-06
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-294374

## Issuer

- Name: Antidote Therapeutics, Inc.
- CIK: 0001716110
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 708 QUINCE ORCHARD ROAD, GAITHERSBURG, MD, 20878
- Phone: 301-365-5385

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Kenneth C Carter | Director | SYKESVILLE, MD |
| Matthew W Kalnik, PhD | Director | Gaithersburg, MD |
| Matthew W Kalnik, PhD | Executive Officer | Gaithersburg, MD |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2017-09-05](https://search.stillhousedata.com/formd/0001716110-17-000001) | D | $432K | $432K |

## More

- [CIK 1716110 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1716110&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001716110-17-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.